Inflammation in diabetic encephalopathy is prevented by C-peptide

Review of Diabetic Studies

Volumn 6, Issue 1, 2009, Pages 37-42

  Sima, Anders A F ^a   Zhang, Weixian ^a   Kreipke, Christian W ^b   Rafols, José A ^b   Hoffman, William H ^c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Bb Wor rat; C peptide; Encephalopathy; Hippocampus; Inflammation; Nf B; RAGE; Type 1 diabetes

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; C PEPTIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTE; BRAIN DISEASE; BRAIN PROTECTION; CONTROLLED STUDY; DIABETIC BB WOR RAT; DIABETIC ENCEPHALOPATHY; HIPPOCAMPUS; IMMUNE RESPONSE; INNATE IMMUNITY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; RAT STRAIN; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; UPREGULATION;

EID: 67649220835     PISSN: 16136071     EISSN: 16140575     Source Type: Journal    
DOI: 10.1900/RDS.2009.6.37     Document Type: Article

References (36)

1. Biessels GJ, Deary IJ, Ryan CM. Cognition and diabetes: a life span perspective. Lancet Neurol 2008. 7:184-190.
2. Ferguson SC, Blane A, Wardlaw J, Frier BM, Perros P, McCrimman RJ, Deary IJ. Influence of early onset age of type 1 diabetes on cerebral structure and cognitive function. Diabetes Care 2005. 28:1431-1437. (Pubitemid 40756709)
3. Schoenle EJ, Shoenle D, Molinari L, Largo RH. Impaired intellectual development in children with type 1 diabetes: association with HbA(1c), age of diagnosis and sex. Diabetologia 2002. 45:108-114. (Pubitemid 34118548)
4. Biessels GJ, Kamal A, Urban IJ, Spruijt BM, Erkelens DW, Gispen WH. Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment. Brain Res 1998. 800(1):125-135. (Pubitemid 28361929)
5. Sima AA, Li ZG. The effect of C-peptide on cognitive dysfunction and hippocampal apoptosis in type 1 diabetes. Diabetes. 2005. 54:1497-1505. (Pubitemid 40586682)
6. Perantie DC, Wu J, Koller JM, Lim A, Warren SL, Black KJ, Sadler M, White NH, Hershey T. Regional brain volume differences associated with hyperglycemia and severe hypoglycemia in youth with type 1 diabetes. Diabetes Care 2007. 30:2331-2337. (Pubitemid 47359042)
7. Hoffman WH, Artlett CM, Zhang W, Kreipke CW, Passmore GG, Rafols JA, Sima AA. Receptor for advanced glycation end products and neuronal deficit in fatal brain edema of diabetic ketoacidosis. Brain Res 2008. 1238:154-162.
8. Francis GJ, Martinez JA, Liu WQ, Xu K, Ayer A, Fine J, Tuor UI, Glazner G, Hanson LR, Frey WH 2nd, Toth C. Intranasal insulin prevents cognitive decline, cerebral atrophy and white matter changes in murine type I diabetic encephalopathy. Brain 2008. 131(Pt 12):3311-3334.
9. Requena JR, Baynes JW. Studies in animal models on the role of glycation and advanced glycation end-products (AGE's) in the pathogenesis of diabetic complications: pitfalls and limitations. In: Sima AAF (ed). Chronic Complications in Diabetes. Harwood Acad Publ, Amsterdam 2000, pp 43-70.
10. Schalkwijk CG, Stehouwer CD, Hinsbergh VW. Fructose-mediated non-enzymatic glycation: sweet coupling or bad modification. Diab Metab Res Rev 2004. 20:369-382. (Pubitemid 39302962)
11. Kuhad A, Bishnoi M, TiWari V, Chopra K. Suppression of NF-kappa beta signaling pathway by tocotrienol can prevent diabetes associated cognitive deficits. Pharmacol Biochem Behav 2009. 92:251-259.
12. Kamboj SS, Chopra K, Sandhir R. Neuroprotective effect of N-acetylcystein in the development of diabetic encephalopathy in streptozotocin-induced diabetes. Brain Dis 2008. 23:427-443.
13. Lin L. RAGE on the toll road? Cell Mol Immunol 2006. 3:351-358.
14. Sima AA, Zhang W, Hoffman WH. Apoptosis of oligodendroglia cells contributes to white matter changes in type 1 diabetic encephalopathy. Proc Neurodiab XVIII. 2008. 94.
15. Toth C, Schmidt AM, Tuor UI, Francis G, Foniok T, Brusse V, Kaur J, Yan SF, Martinez JA, Barber PA, Cuchan A, Zochodne DW. Diabetes, leucoencephalopathy and rage. Neurobiol Dis 2006. 23:445-461.
16. Morris R. Development of a water maze procedure for studying spatial learning in the rat. J Neurosci 1984. 11:47-60. (Pubitemid 14088970)
17. Ahmed N, Ahmed U, Thornalley PJ, Hager K, Fleischer G, Munch G. Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairment. J Neurochem 2005. 92:255-263. (Pubitemid 40194017)
18. Neeper M, Schmidt AM, Brett J, Jan SD, Wang F, Pan YL, Elliston K, Stern D, Shaw A. Cloning and expression of RAGE: a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 1992. 267:14998-15004.
19. Ramasamy R, Vanucci SJ, Yan SD, Herold K, Yan SF, Schmidt AM. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration and inflammation. Glycobiology 2004. 15:16R-28R.
20. Grunberger G, Qiang X, Li ZG, Mathews ST, Sbriessa D, Shisheva A, Sima AA. Molecular basis for the insulinomimetic effects of C-peptide. Diabetologia 2001. 44:1247-1257 (Pubitemid 33010501)
21. Li ZG, Qiang X, Sima AA, Grunberger G. C-peptide attenuates protein tyrosine phosphatase activity and enhances glycogen synthesis in L6 myoblasts. Biochem Biophys Res Com 2001. 26:615-619. (Pubitemid 32924473)
22. Sima AA, Zhang W, Li ZG, Murakawa Y, Pierson CR. Molecular alterations underlie nodal and paranodal degeneration in type 1 diabetic neuropathy and are prevented by C-peptide. Diabetes 2004. 53:1556-1563. (Pubitemid 38697669)
23. Yan SD, Chen X, Schmidt AM, Brett J, Godman G, Scott CW, Caputo C, Frappier T, Yen SH, Stein D. The presence of glycated tau in Alzheimer's disease: a mechanism for induction of oxidant stress. PNAS (USA) 1994. 91:7787-7791. (Pubitemid 24238270)
24. Li ZG, Zhang W, Sima AA. C-peptide enhances insulin-mediated cell growth and protection against high glucose induced apoptosis in SH-SY5Y cells. Diab Metab Res Rev 2003. 19:375-385. (Pubitemid 37185378)
25. Hayden MS, Shosh S. Signaling to NF-kappaB. Genes Dev 2004. 18(18):2195-2224.
26. Cifarelli V, Luppi P, Tse HM, He J, Piganelli J, Trucco M. Human proinsulin C-peptide reduces high glucose-induced proliferation and NF-kappaB activation in vascular smooth muscle cells. Atherosclerosis 2008. 201:248-257.
27. Bierhaus A, Schiekofer S, Schwarninger M, Andrassy M, Humpert PM, Chen J, Hong M, Luther T, Henle T, Klöting I, Morcos M, Hoffman M, Tritschler H, Weigle B, Kasper M, Smith M, Perry G, Schmidt AM, Stern DM, Häring HU, Schleicher E, Nawroth PP. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes 2001. 50:2792-2808.
28. Mukherjee TK, Mukhopadhyay S, Hoidal JR. The role of reactive oxygen species in TNF alpha-dependent expression of the receptor for advanced glycation end products in human umbilical vein endothelial cells. Biochim Biophys Acta 2005. 1744:213-223. (Pubitemid 40798926)
29. Li J, Schmidt AM. Characterization and functional analysis of the promotor of RAGE, the receptor for advanced glycation end products. J Biol Chem 1997. 272:16498-16506. (Pubitemid 27276477)
30. Li ZG, Zhang W, Sima AA. Alzheimer-like changes in rat models of spontaneous diabetes. Diabetes 2007. 56:1817-1824. (Pubitemid 47025451)
31. Stein D, Yan SD, Yan SF, Schmidt AM. Receptor for advanced glycation end products: a multiligand receptor magnifying cell stress in diverse pathologic settings. Adv Drug Deliv Rev 2002. 54:1615-1625.
32. Hoffman MA, Drury S, Fu C, Qu W, Tagushi A, Lu Y, Avila C, Kambham N, Bierhaus A, Nawroth P, Neurath MF, Slattery T, Beach D, McClary J, Nagashima M, Morser J, Stern D, Schmidt AM. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999. 97:889-901. (Pubitemid 29375048)
33. Karin M. Inflammation-activated protein kinases as targets for drug development. Proc Am Thorac Soc 2005. 2:380-390. (Pubitemid 41699701)
34. Sima AA, Kamiya H, Li ZG. Insulin, C-peptide, hyperglycemia and central nervous system complications in diabetes. Eur J Pharmacol 2004. 490(1-3):187-197. (Pubitemid 38482172)
35. Goetze S, Blaschke F, Stawowy P, Bruemmer D, Spencer C, Graf K, Gräfe M, Law RE, Fleck E. TNF-alpha inhibits insulin's anti-apoptotic signaling in vascular smooth muscle cells. Biochem Biophys Res Commun 2001. 287:662-670. (Pubitemid 32912765)
36. Li ZG, Zhang W, Sima AA. The role of impaired insulin/ IGF action in primary diabetic encephalopathy. Brain Res 2005. 1037:12-24. (Pubitemid 40362377)